Literature DB >> 31727376

Accuracy and incremental yield of urine Xpert MTB/RIF Ultra versus Determine TB-LAM for diagnosis of pulmonary tuberculosis.

A Andama1, D Jaganath2, R Crowder3, L Asege4, M Nakaye4, D Katumba4, S Mwebe4, F Semitala5, W Worodria6, M Joloba7, S Mohanty8, A Somoskovi9, A Cattamanchi10.   

Abstract

The performance of urine Xpert MTB/RIF Ultra (Xpert Ultra) for pulmonary TB diagnosis is unknown. HIV-positive and HIV-negative adults were enrolled at two health facilities in Kampala, Uganda. We compared the accuracy of urine Xpert Ultra and Determine TB-LAM in reference to sputum-based testing (positive Xpert MTB/RIF or culture), and assessed incremental yield. Urine Xpert Ultra had low sensitivity (17.2%, 95% CI 12.3-23.2) but high specificity (98.1%, 95% CI 94.4-99.6). Sensitivity reached 50.0% (95% CI 28.2-71.8) among HIV-positive patients with CD4 <100 cells/μL. Compared to Determine TB-LAM, urine Xpert Ultra was 9.4% (95% CI 3.8-14.9, P = 0.01) more sensitive, and 17.2% (95% CI 4.5-29.8, P = 0.01) more sensitive among HIV-positive patients. However, the incremental sensitivity of urine Xpert Ultra relative to sputum Xpert MTB/RIF was only 1% (95% CI -0.9 to 2.8). Urine Xpert Ultra could be an alternative for patients with advanced HIV infection unable to produce sputum.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostics; Lipoarabinomannan; Tuberculosis; Urine; Xpert ultra

Mesh:

Substances:

Year:  2019        PMID: 31727376      PMCID: PMC6906254          DOI: 10.1016/j.diagmicrobio.2019.114892

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  23 in total

1.  Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.

Authors:  Maunank Shah; Willy Ssengooba; Derek Armstrong; Lydia Nakiyingi; Molly Holshouser; Jerrold J Ellner; Moses Joloba; Yukari C Manabe; Susan E Dorman
Journal:  AIDS       Date:  2014-06-01       Impact factor: 4.177

Review 2.  Diagnostic accuracy of the Xpert® MTB/RIF assay for extra-pulmonary tuberculosis: a meta-analysis.

Authors:  E Penz; J Boffa; D J Roberts; D Fisher; R Cooper; P E Ronksley; M T James
Journal:  Int J Tuberc Lung Dis       Date:  2015-03       Impact factor: 2.373

3.  Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  David J Horne; Mikashmi Kohli; Jerry S Zifodya; Ian Schiller; Nandini Dendukuri; Deanna Tollefson; Samuel G Schumacher; Eleanor A Ochodo; Madhukar Pai; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2019-06-07

4.  Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa.

Authors:  Stephen D Lawn; Andrew D Kerkhoff; Rosie Burton; Charlotte Schutz; Gavin van Wyk; Monica Vogt; Pearl Pahlana; Mark P Nicol; Graeme Meintjes
Journal:  BMC Med       Date:  2015-08-14       Impact factor: 8.775

5.  Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.

Authors:  Jonny Peter; Grant Theron; Duncan Chanda; Petra Clowes; Andrea Rachow; Maia Lesosky; Michael Hoelscher; Peter Mwaba; Alex Pym; Keertan Dheda
Journal:  BMC Infect Dis       Date:  2015-07-09       Impact factor: 3.090

6.  Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.

Authors:  Helena Huerga; Gabriella Ferlazzo; Paolo Bevilacqua; Beatrice Kirubi; Elisa Ardizzoni; Stephen Wanjala; Joseph Sitienei; Maryline Bonnet
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

7.  Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity.

Authors:  Luisa Paris; Ruben Magni; Fatima Zaidi; Robyn Araujo; Neal Saini; Michael Harpole; Jorge Coronel; Daniela E Kirwan; Hannah Steinberg; Robert H Gilman; Emanuel F Petricoin; Roberto Nisini; Alessandra Luchini; Lance Liotta
Journal:  Sci Transl Med       Date:  2017-12-13       Impact factor: 17.956

Review 8.  Toward the Development of a Circulating Free DNA-Based In Vitro Diagnostic Test for Infectious Diseases: a Review of Evidence for Tuberculosis.

Authors:  B Leticia Fernández-Carballo; Tobias Broger; Romain Wyss; Niaz Banaei; Claudia M Denkinger
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 9.  Xpert MTB/RIF Ultra for Tuberculosis Testing in Children: A Mini-Review and Commentary.

Authors:  Rachel R Atherton; Fiona V Cresswell; Jayne Ellis; Sabrina B Kitaka; David R Boulware
Journal:  Front Pediatr       Date:  2019-02-28       Impact factor: 3.418

10.  The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.

Authors:  Soumitesh Chakravorty; Ann Marie Simmons; Mazhgan Rowneki; Heta Parmar; Yuan Cao; Jamie Ryan; Padmapriya P Banada; Srinidhi Deshpande; Shubhada Shenai; Alexander Gall; Jennifer Glass; Barry Krieswirth; Samuel G Schumacher; Pamela Nabeta; Nestani Tukvadze; Camilla Rodrigues; Alena Skrahina; Elisa Tagliani; Daniela M Cirillo; Amy Davidow; Claudia M Denkinger; David Persing; Robert Kwiatkowski; Martin Jones; David Alland
Journal:  mBio       Date:  2017-08-29       Impact factor: 7.867

View more
  13 in total

1.  Evaluating the efficacy of stool sample on Xpert MTB/RIF Ultra and its comparison with other sample types by meta-analysis for TB diagnostics.

Authors:  Vishal Sharma; Anoop Singh; Mohita Gaur; Deepti Rawat; Anjali Yadav; Chanchal Kumar; Mandira Varma-Basil; Sheelu Lohiya; Vishal Khanna; Ashwani Khanna; Anil Chaudhry; Yogendra Singh; Richa Misra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-04       Impact factor: 3.267

2.  Detection of pulmonary tuberculosis in children using the Xpert MTB/RIF Ultra assay on sputum: a multicenter study.

Authors:  Xiaoshan Peng; Qiong Liao; Min Fang; Yu Zhu; Yan Shi; Shuting Quan; Yacui Wang; Li Duan; Xiaomei Shi; Yang Liu; Manzhi Wang; Qingsong Wei; Haiyi Zhou; Yanchun Wang; Xirong Wu; Yao Yao; Lin Sun; Adong Shen; Chaomin Wan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-11-04       Impact factor: 3.267

3.  Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries.

Authors:  Celine Perier; Emmanuel Nasinghe; Isabelle Charles; Leoson Junior Ssetaba; Vida Ahyong; Derek Bangs; P Robert Beatty; Nadine Czudnochowski; Amy Diallo; Eli Dugan; Jacqueline M Fabius; Hildy Fong Baker; Jackson Gardner; Stephen Isaacs; Birungi Joanah; Katrina Kalantar; David Kateete; Matt Knight; Maria Krasilnikov; Nevan J Krogan; Chaz Langelier; Eric Lee; Lucy M Li; Daniel Licht; Katie Lien; Zilose Lyons; Gerald Mboowa; Ivan Mwebaza; Savannah Mwesigwa; Geraldine Nalwadda; Robert Nichols; Maria Elena Penaranda; Sarah Petnic; Maira Phelps; Stephen J Popper; Michael Rape; Arthur Reingold; Richard Robbins; Oren S Rosenberg; David F Savage; Samuel Schildhauer; Matthew L Settles; Ivan Sserwadda; Sarah Stanley; Cristina M Tato; Alexandra Tsitsiklis; Erik Van Dis; Manu Vanaerschot; Joanna Vinden; Jeffery S Cox; Moses L Joloba; Julia Schaletzky
Journal:  Glob Health Action       Date:  2022-12-31       Impact factor: 2.996

4.  Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.

Authors:  Mitch M Matoga; Gregory P Bisson; Amita Gupta; Sachiko Miyahara; Xin Sun; Carrie Fry; Yukari C Manabe; Johnstone Kumwenda; Kanyama Cecilia; Mulinda Nyirenda; McNeil Ngongondo; Abineli Mbewe; David Lagat; Carole Wallis; Henry Mugerwa; Mina C Hosseinipour
Journal:  Clin Infect Dis       Date:  2021-08-16       Impact factor: 20.999

5.  Progress toward Developing Sensitive Non-Sputum-Based Tuberculosis Diagnostic Tests: the Promise of Urine Cell-Free DNA.

Authors:  Emily MacLean; Ruvandhi R Nathavitharana
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

6.  The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda.

Authors:  A Andama; D Jaganath; R Crowder; L Asege; M Nakaye; D Katumba; J Mukwatamundu; S Mwebe; C F Semitala; W Worodria; M Joloba; S Mohanty; A Somoskovi; A Cattamanchi
Journal:  BMC Infect Dis       Date:  2021-01-11       Impact factor: 3.090

7.  Xpert MTB/RIF Ultra Is Highly Sensitive for the Diagnosis of Tuberculosis Lymphadenitis in a High-HIV Setting.

Authors:  Stephanie Minnies; Byron W P Reeve; Loren Rockman; Georgina Nyawo; Charissa C Naidoo; Natasha Kitchin; Cornelia Rautenbach; Colleen A Wright; Andrew Whitelaw; Pawel Schubert; Robin M Warren; Grant Theron
Journal:  J Clin Microbiol       Date:  2021-09-01       Impact factor: 5.948

8.  Diagnostic value of Lipoarabinomannan antigen for detecting Mycobacterium tuberculosis in adults and children with or without HIV infection.

Authors:  Xin Yin; Qi-Qing Ye; Ke-Fan Wu; Ji-Yuan Zeng; Nan-Xi Li; Jun-Jian Mo; Pei-Ying Huang; Li-Min Xie; Li-Ying Xie; Xu-Guang Guo
Journal:  J Clin Lab Anal       Date:  2022-01-16       Impact factor: 2.352

9.  Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study.

Authors:  Robert Ndege; Omary Ngome; Farida Bani; Yvan Temba; Herieth Wilson; Fiona Vanobberghen; Jerry Hella; Winfrid Gingo; Mohamed Sasamalo; Dorcas Mnzava; Namvua Kimera; Helen Hiza; John Wigayi; Herry Mapesi; Irene B Kato; Francis Mhimbira; Klaus Reither; Manuel Battegay; Daniel H Paris; Maja Weisser; Martin Rohacek
Journal:  BMC Infect Dis       Date:  2020-05-15       Impact factor: 3.090

10.  Standardized Urine-Based Tuberculosis (TB) Screening With TB-Lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan Adults With Advanced Human Immunodeficiency Virus Disease and Suspected Meningitis.

Authors:  Fiona V Cresswell; Jayne Ellis; Enock Kagimu; Ananta S Bangdiwala; Michael Okirwoth; Gerald Mugumya; Morris Rutakingirwa; John Kasibante; Carson M Quinn; Kenneth Ssebambulidde; Joshua Rhein; Edwin Nuwagira; Lillian Tugume; Emily Martyn; Caleb P Skipper; Conrad Muzoora; Daniel Grint; David B Meya; Nathan C Bahr; Alison M Elliott; David R Boulware
Journal:  Open Forum Infect Dis       Date:  2020-03-24       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.